Publication:

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins

Thumbnail Image

Open/View Files

4220464.pdf (667.16 KB)

Date

2014

Authors

Published Version

10.1038/ncomms6068

Journal Title

Journal ISSN

Volume Title

Publisher

Nature Pub. Group
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Postmus, I., S. Trompet, H. A. Deshmukh, M. R. Barnes, X. Li, H. R. Warren, D. I. Chasman, et al. 2014. “Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.” Nature Communications 5 (1): 5068. doi:10.1038/ncomms6068. http://dx.doi.org/10.1038/ncomms6068.

Abstract

Statins effectively lower LDL cholesterol levels in large studies and the observed interindividual response variability may be partially explained by genetic variation. Here we perform a pharmacogenetic meta-analysis of genome-wide association studies (GWAS) in studies addressing the LDL cholesterol response to statins, including up to 18,596 statin-treated subjects. We validate the most promising signals in a further 22,318 statin recipients and identify two loci, SORT1/CELSR2/PSRC1 and SLCO1B1, not previously identified in GWAS. Moreover, we confirm the previously described associations with APOE and LPA. Our findings advance the understanding of the pharmacogenetic architecture of statin response.

Description

Other Available Sources

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220464/pdf/

Research Data

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

URI

http://nrs.harvard.edu/urn-3:HUL.InstRepos:13454864

Collections

HMS Scholarly Articles

Endorsement

Review

Supplemented By

Related Stories